Download the full article (PDF) Introduction Antibodies are cornerstone molecules of adaptive immunity and have become central to therapeutic and diagnostic biotechnology. Classical antibodies (e.g., human IgG) comprise two heavy and two light chains, forming a complex quaternary structure that delivers high-affinity, high-specificity binding to antigens. However, in the 1990s, researchers discovered that members […]
Download the full article (PDF) Introduction Antibodies are cornerstone molecules of adaptive immunity and have become central to therapeutic and diagnostic biotechnology. Classical antibodies (e.g., human IgG) comprise two
Download the full article (PDF) Introduction The landscape of targeted cancer therapy has expanded dramatically with the advent of sophisticated small-molecule modalities capable of modulating oncogenic proteins through mechanisms
Download the full article (PDF) Introduction Antibody oligonucleotide conjugates (AOCs) represent an emerging class of biotherapeutics that combine the cell-targeting precision of antibodies with the gene-modulating capabilities of oligonucleotides. Structurally,
Download the full article (PDF) Introduction Immunocytokines, which are fusion proteins combining a cytokine with an antibody or antibody fragment, constitute a rapidly advancing class of targeted immunotherapeutics. They
Introduction Cancer treatment has undergone a dramatic transformation in recent years, moving from broad cytotoxic chemotherapies toward molecularly precise strategies tailored to specific genetic, epigenetic, and proteomic vulnerabilities. The
G Protein Coupled Receptors (GPCRs) represent a vast and diverse family of membrane proteins that are central to the regulation of human immune cell function. These receptors mediate responses
Introduction Autoimmune diseases constitute a complex group of disorders in which immune system dysregulation leads to chronic inflammation and tissue damage. Among these diseases, rheumatoid arthritis (RA), inflammatory bowel disease
With 30+ years of expertise in cell-based potency assay development, we provide accurate, GMP-compliant assays for AAV vectors and gene therapy candidates, ensuring a faster path to clinical success. Click
Radiopharmaceutical Drugs Radiopharmaceutical therapy (RPT), also known as radioligand therapy (RLT), is emerging as a novel and promising approach to combat cancer. This innovative therapeutic method harnesses the potency of radioactive substances, termed radioligands, to
There are two principal immunological test formats used to check for the presence of anti-SARS-CoV-2 antibodies in blood as evidence of a previous COVID-19 infection. One is enzyme-linked immunosorbent assay
